Skip to main content
Top
Published in: Virology Journal 1/2012

Open Access 01-12-2012 | Short report

Ano-genital human papillomavirus type 97 infection is detected in Canadian men but not women at risk or infected with the human immunodeficiency virus

Authors: Marie-Eve Landry, Irving E Salit, Catherine Rodrigues-Coutlée, Deborah Money, Anu Rebbapragada, Jill Tinmouth, Catherine Hankins, Isabelle Gorska-Flipot, Jacques Archambault, Eduardo L Franco, François Coutlée

Published in: Virology Journal | Issue 1/2012

Login to get access

Abstract

Background

Human papillomavirus type 97 (HPV97) DNA was detected in nearly 5% of anal samples collected from HIV-seropositive men living in Montreal, Canada. The rate of detection of HPV97 in the genital tract of Canadian women is unknown. Whether HPV97 is a local epidemic in HIV-seropositive men living in Montreal is also unknown. The prevalence of human papillomavirus type 97 (HPV97) was assessed in cervicovaginal cells from women living in Canada and in anal samples from HIV-seropositive men living in Toronto.

Findings

Cervicovaginal lavages collected from 904 women (678 HIV-seropositive, 226 HIV-seronegative) women living in Canada and anal cells collected from 123 HIV-seropositive men living in Toronto were tested for the presence of HPV97 with PCR. HPV97-positive samples were further tested by PCR-sequencing for molecular variant analysis to assess if all HPV97-positive men were infected with the same strain. All cervicovaginal samples were negative for HPV97. HPV97 was detected in anal samples from 6 HIV-seropositive men (4.9%, 95% confidence interval 2.0-10.5%), of whom five had high-grade and one had low-grade anal intraepithelial neoplasia, in addition to 2 to 8 HPV genital genotypes per sample. Four HPV97 variants were defined by four variation sites in the viral control region.

Conclusion

These findings indicate that HPV97 infects in the anal canal of HIV-seropositive men but is not detected in the genital tract of women.
Literature
1.
go back to reference Chen Z, Fu L, Herrero R, Schiffman M, Burk RD: Identification of a novel human papillomavirus (HPV97) related to HPV18 and HPV45. Int J Cancer. 2007, 121: 193-198. 10.1002/ijc.22632.PubMedCrossRef Chen Z, Fu L, Herrero R, Schiffman M, Burk RD: Identification of a novel human papillomavirus (HPV97) related to HPV18 and HPV45. Int J Cancer. 2007, 121: 193-198. 10.1002/ijc.22632.PubMedCrossRef
2.
go back to reference Gorska-Flipot I, Sawicki J, Gaboury L, et al: Newly isolated HPV97 related to HPV18 and HPV45 is highluy prevalent in HIV positive males from the Montreal area. Int J Cancer. 2008, 122: 1195-1197.PubMedCrossRef Gorska-Flipot I, Sawicki J, Gaboury L, et al: Newly isolated HPV97 related to HPV18 and HPV45 is highluy prevalent in HIV positive males from the Montreal area. Int J Cancer. 2008, 122: 1195-1197.PubMedCrossRef
3.
go back to reference Hankins C, Coutlee F, Lapointe N, et al: Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Can Med Ass J. 1999, 160: 185-191. Hankins C, Coutlee F, Lapointe N, et al: Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Can Med Ass J. 1999, 160: 185-191.
4.
go back to reference Herrero R, Castle PE, Schiffman M, et al: Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis. 2005, 191: 1796-1807. 10.1086/428850.PubMedCrossRef Herrero R, Castle PE, Schiffman M, et al: Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis. 2005, 191: 1796-1807. 10.1086/428850.PubMedCrossRef
5.
go back to reference de Pokomandy A, Rouleau D, Ghattas G, et al: Prevalence, clearance and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. Journal of Infectious Disease. 2009, 199: 965-973. 10.1086/597207.CrossRef de Pokomandy A, Rouleau D, Ghattas G, et al: Prevalence, clearance and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. Journal of Infectious Disease. 2009, 199: 965-973. 10.1086/597207.CrossRef
6.
go back to reference Chen Z, Schiffman M, Herrero R, et al: Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One. 2011, 6: e20183-10.1371/journal.pone.0020183.PubMedPubMedCentralCrossRef Chen Z, Schiffman M, Herrero R, et al: Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One. 2011, 6: e20183-10.1371/journal.pone.0020183.PubMedPubMedCentralCrossRef
7.
go back to reference Giannoudis A, Herrington CS: Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol. 2001, 193: 295-302. 10.1002/1096-9896(2000)9999:9999<::AID-PATH809>3.0.CO;2-C.PubMedCrossRef Giannoudis A, Herrington CS: Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol. 2001, 193: 295-302. 10.1002/1096-9896(2000)9999:9999<::AID-PATH809>3.0.CO;2-C.PubMedCrossRef
8.
go back to reference Gagnon S, Hankins C, Tremblay C, et al: Polymorphism of HPV-33 and HPV-35 is associated with persistence of HPV infection. J Inf Dis. 2004, 190: 1575-1585. 10.1086/424854.CrossRef Gagnon S, Hankins C, Tremblay C, et al: Polymorphism of HPV-33 and HPV-35 is associated with persistence of HPV infection. J Inf Dis. 2004, 190: 1575-1585. 10.1086/424854.CrossRef
9.
go back to reference Khouadri S, Villa LL, Gagnon S, et al: Human papillomavirus type 33 polymorphism and high-grade lesions of the uterine cervix. J Inf Dis. 2006, 194: 886-894. 10.1086/507431.CrossRef Khouadri S, Villa LL, Gagnon S, et al: Human papillomavirus type 33 polymorphism and high-grade lesions of the uterine cervix. J Inf Dis. 2006, 194: 886-894. 10.1086/507431.CrossRef
10.
go back to reference Aho J, Hankins C, Tremblay C, et al: Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women. J Infect Dis. 2003, 188: 1517-1527. 10.1086/379198.PubMedCrossRef Aho J, Hankins C, Tremblay C, et al: Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women. J Infect Dis. 2003, 188: 1517-1527. 10.1086/379198.PubMedCrossRef
11.
go back to reference Bernard HU, Calleja-Macias IE, Dunn ST: Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer. 2006, 118: 1071-1076. 10.1002/ijc.21655.PubMedCrossRef Bernard HU, Calleja-Macias IE, Dunn ST: Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer. 2006, 118: 1071-1076. 10.1002/ijc.21655.PubMedCrossRef
12.
go back to reference Coutlée F, Hankins C, Lapointe N, et al: Comparison betwen vaginal tampon and cervicovaginal lavage specimens collection for detection of human papillomavirus DNA by the polymerase chain reaction. J Med Virol. 1997, 51: 42-47. 10.1002/(SICI)1096-9071(199701)51:1<42::AID-JMV7>3.0.CO;2-S.PubMedCrossRef Coutlée F, Hankins C, Lapointe N, et al: Comparison betwen vaginal tampon and cervicovaginal lavage specimens collection for detection of human papillomavirus DNA by the polymerase chain reaction. J Med Virol. 1997, 51: 42-47. 10.1002/(SICI)1096-9071(199701)51:1<42::AID-JMV7>3.0.CO;2-S.PubMedCrossRef
13.
go back to reference Salit I, Tinmouth J, Chong S, Raboud J, Diong C, Su D: Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology. Cancer Epidemiol Biom Prev. 2010, 18: 1986-1992.CrossRef Salit I, Tinmouth J, Chong S, Raboud J, Diong C, Su D: Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology. Cancer Epidemiol Biom Prev. 2010, 18: 1986-1992.CrossRef
Metadata
Title
Ano-genital human papillomavirus type 97 infection is detected in Canadian men but not women at risk or infected with the human immunodeficiency virus
Authors
Marie-Eve Landry
Irving E Salit
Catherine Rodrigues-Coutlée
Deborah Money
Anu Rebbapragada
Jill Tinmouth
Catherine Hankins
Isabelle Gorska-Flipot
Jacques Archambault
Eduardo L Franco
François Coutlée
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2012
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-9-243

Other articles of this Issue 1/2012

Virology Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.